Pliant Therapeutics (PLRX) Return on Sales (2020 - 2024)
Pliant Therapeutics (PLRX) reported Return on Sales of 6.88% for Q1 2024, down 660.0% year-over-year from 1.23% in Q2 2023, and down 574.24% quarter-over-quarter from 1.02% in Q4 2023.
Pliant Therapeutics (PLRX) Return on Sales (2020 - 2024) Analysis & Trends
Pliant Therapeutics (PLRX) has 5 years of Return on Sales data on file, last reported at 6.88% in Q1 2024.
- Return on Sales for Q1 2024 came in at 6.88%, down 660.0% year-over-year; the trailing twelve-month figure through Mar 2024 was 6.88% (down 675.0% YoY), and the FY2023 annual result was 1.02%, down 89.0% from the prior year.
- Return on Sales eased to 6.88% in Q1 2024 per PLRX's latest filing, from 1.02% in the prior quarter.
- Over five years, Return on Sales peaked at 0.0% in Q1 2020 and troughed at 6.88% in Q1 2024.
- A 5-year average of 0.68% and a median of 0.17% in 2021 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2022 and 2024: Return on Sales grew 7 bps in 2022, then sank 660 bps in 2024.
- A 5-year view of Return on Sales shows it stood at 0.04% in 2020, then sank by 188 bps to 0.12% in 2021, then sank by 45 bps to 0.18% in 2022, then tumbled by 472 bps to 1.02% in 2023, then slumped by 574 bps to 6.88% in 2024.
- Business Quant data shows PLRX's Return on Sales at 6.88% in Q1 2024, 1.02% in Q4 2023, and 0.44% in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -6.88% |
| Dec 31, 2023 | -1.02% |
| Sep 30, 2023 | -0.44% |
| Jun 30, 2023 | -1.66% |
| Mar 31, 2023 | -0.28% |
| Dec 31, 2022 | -0.18% |
| Sep 30, 2022 | -0.21% |
| Jun 30, 2022 | -0.06% |
| Mar 31, 2022 | -0.22% |
| Dec 31, 2021 | -0.12% |
| Sep 30, 2021 | -0.17% |
| Jun 30, 2021 | -0.13% |
| Mar 31, 2021 | -0.11% |
| Dec 31, 2020 | -0.04% |
| Sep 30, 2020 | -0.03% |
| Jun 30, 2020 | -0.05% |
| Mar 31, 2020 | 0.00% |